fbpx

Day

februar 5, 2020
CAMBRIDGE, Mass., Feb. 05, 2020 (GLOBE NEWSWIRE) — Spero Therapeutics, Inc. (Nasdaq: SPRO), a multi-asset clinical-stage biopharmaceutical company focused on identifying, developing and commercializing treatments in high unmet need areas involving multi-drug resistant (MDR) bacterial infections and rare diseases, announced today that the Biomedical Advanced Research and Development Authority (BARDA) has exercised its first contract option for additional committed...

Nyheder

Ny test kan afsløre farlige modermærker
14. februar 2020
Brainy Days – rejs med ind i hjernen
10. februar 2020
Astma programmeres tidligt i livet
7. februar 2020

Lundbeckfonden

Lundbeckfonden Ventures

Lundbeckfonden Emerge